7 citations
,
May 2022 in “The Journal of Dermatology” This narrative review found that post-COVID-19 hair loss, particularly telogen effluvium, poses a significant mental and social burden, with minoxidil potentially aiding recovery, although more clinical research is needed to confirm its effectiveness.
3 citations
,
April 2022 in “Clinical, Cosmetic and Investigational Dermatology” This review discusses evidence-based complementary strategies for enhancing hair regrowth after post-COVID-19 telogen effluvium and reports no new clinical results.
1 citations
,
August 2022 in “Медицинский совет” This study reported that among patients aged 19 to 60 who experienced hair loss after COVID-19, a treatment involving a complex drug and peptide lotion led to hair improvement in 92% of cases, with good tolerability and no reported side effects.
8 citations
,
January 2022 in “Cureus” This case study reports a patient with post-COVID-19 diffuse alopecia who experienced gradual hair recovery to near pre-infection levels within seven months.
2 citations
,
June 2021 in “Медицинский совет” This article discusses COVID-19-induced hair loss, noting that both the infection and related stress may contribute to diffuse thinning and androgenic alopecia, and emphasizes the importance of dermatological evaluation.